Although the increased phospho-EGFR expression in the MUP-uPA background liver was attenuated by HNK treatment, HNK treatment clearly suppressed EGFR and FKBP5 protein expressions in the background NASH liver. This evidence concerns the gene PLAU and metabolic dysfunction-associated steatohepatitis.